title: Do sulfonylureas influence hepatic insulin clearance?
authors.forename: L C
authors.initials: LC
authors.lastname: Groop
authors.forename: P H
authors.initials: PH
authors.lastname: Groop
authors.forename: S
authors.initials: S
authors.lastname: Stenman
authors.forename: C
authors.initials: C
authors.lastname: Saloranta
authors.forename: K J
authors.initials: KJ
authors.lastname: Tötterman
authors.forename: F
authors.initials: F
authors.lastname: Fyhrquist
authors.forename: A
authors.initials: A
authors.lastname: Melander
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds